These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18959012)

  • 1. [Alteplase in acute coronary syndromes].
    Iturbe Orbe M; Jerjes-Sánchez Diaz C; García-Sosa A; García H; Reyes Cerezo E; Fernández D; Garza Ruiz A; Assad C; Castillo F; González M; García J; Valadéz F; Chávez M; Garza O
    Arch Cardiol Mex; 2008; 78(3):255-64. PubMed ID: 18959012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Małopolska Registry of Acute Coronary Syndromes 2005-2006.
    Dudek D; Siudak Z; Dziewierz A; Rakowski T; Mielecki W; Brzeziński M; Zasada W; Bartuś S; Januś B; Dubiel JS
    Kardiol Pol; 2008 May; 66(5):489-97, discussion 498-9. PubMed ID: 18537056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
    Grajek S; Lesiak M; Araszkiewicz A; Pyda M; Skorupski W; Grygier M; Mitkowski P; Prech M; Baszko A; Janus M; Breborowicz P; Rzeźniczak J; Tarchalski J; Główka A; Cieśliński A
    Kardiol Pol; 2008 Feb; 66(2):154-63; discussion 164-5. PubMed ID: 18344153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexican Registry of Acute Coronary Syndromes.
    García-Castillo A; Jerjes-Sánchez C; Martínez Bermúdez P; Azpiri-López JR; Autrey Caballero A; Martínez Sánchez C; Ramos Corrales MA; Llamas G; Martínez Sánchez J; Treviño AJ;
    Arch Cardiol Mex; 2005; 75 Suppl 1():S6-32. PubMed ID: 16001714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry.
    Diercks DB; Kontos MC; Chen AY; Pollack CV; Wiviott SD; Rumsfeld JS; Magid DJ; Gibler WB; Cannon CP; Peterson ED; Roe MT
    J Am Coll Cardiol; 2009 Jan; 53(2):161-6. PubMed ID: 19130984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes.
    Riezebos RK; Ronner E; Ter Bals E; Slagboom T; Smits PC; ten Berg JM; Kiemeneij F; Amoroso G; Patterson MS; Suttorp MJ; Tijssen JG; Laarman GJ;
    Heart; 2009 May; 95(10):807-12. PubMed ID: 19098058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    McKay RG; Dada MR; Mather JF; Mennet RR; Murphy DJ; Maloney KW; Hirst JA; Kiernan FJ
    Am J Cardiol; 2009 Feb; 103(3):316-21. PubMed ID: 19166682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.
    Schwarz AK; Zeymer U
    Future Cardiol; 2009 Jan; 5(1):43-9. PubMed ID: 19371202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR).
    Zeymer U; Arntz HR; Dirks B; Ellinger K; Genzwürker H; Nibbe L; Tebbe U; Senges J; Schneider S;
    Resuscitation; 2009 Apr; 80(4):402-6. PubMed ID: 19167147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of enoxaparin in emergency room for improving outcomes of primary percutaneous coronary interventions for acute myocardial infarction.
    Abhyankar AD; Pothiawala SE; Kazi GJ; Jha MJ; Petrolwala M
    Indian Heart J; 2008; 60(1):39-44. PubMed ID: 19212020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
    Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
    Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute coronary syndrome (ACS) registry--leading the charge for National Cardiovascular Disease (NCVD) Database.
    Chin SP; Jeyaindran S; Azhari R; Wan Azman WA; Omar I; Robaayah Z; Sim KH
    Med J Malaysia; 2008 Sep; 63 Suppl C():29-36. PubMed ID: 19230244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndrome in 1366 patients at Siriraj Hospital: clinical characteristics, management and in-hospital outcomes.
    Tungsubutra W; Tresukosol D; Krittayaphong R; Panchavinnin P; Chotnaiwattarakul C; Phankingtongkhum R
    J Med Assoc Thai; 2007 Nov; 90 Suppl 2():25-32. PubMed ID: 19230422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.